Cleared Traditional

K241741 - SAFElife™ Fentanyl Urine Home Test (Cassette) (FDA 510(k) Clearance)

Also includes:
SAFElife™ Fentanyl (FTY) Urine Test Cassette SAFElife™ T-Dip Fentanyl Urine Home Test (Dip Card) SAFElife™ T-Dip Fentanyl (FTY) Urine Test Panel
Jul 2024
Decision
29d
Days
Class 2
Risk

K241741 is an FDA 510(k) clearance for the SAFElife™ Fentanyl Urine Home Test (Cassette). This device is classified as a Test, Opiates, Over The Counter (Class II - Special Controls, product code NGL).

Submitted by Guangzhou Wondfo Biotech Co., Ltd. (Guangzhou, CN). The FDA issued a Cleared decision on July 16, 2024, 29 days after receiving the submission on June 17, 2024.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3650.

Submission Details

510(k) Number K241741 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 17, 2024
Decision Date July 16, 2024
Days to Decision 29 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code NGL — Test, Opiates, Over The Counter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3650